WT
VTAE

Wellcome Trust’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Wellcome Trust’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-423,001
Closed -$4.95M – 28
2015
Q1 		$4.95M Sell
423,001
-16,523
-4% -$223K 0.11% 27
2014
Q4 		$7.29M Sell
439,524
-79,886
-15% -$1.17M 0.15% 29
2014
Q3 		$3.96M Buy
+519,410
New +$4.04M 0.08% 30

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellcome Trust's VTAE Position: Q2 2015 in Review

Wellcome Trust sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2015, closing a stake of 423,001 shares — an estimated $4.95M sold.

Wellcome Trust first reported a position in VTAE in Q3 2014 and held it in 3 quarters. The position peaked at $7.29M in Q4 2014. 53 funds tracked by Wall St. Rank hold VTAE as of Q2 2015.

  • Wellcome Trust reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • Wellcome Trust sold 423,001 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2015, an estimated $4.95M.
  • Wellcome Trust first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 3 quarters.
  • Wellcome Trust's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $7.29M in Q4 2014.
  • 53 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2015.

Based on Wellcome Trust's 13F filing for Q2 2015, filed 14 Jul 2015.